|
|
Volumn 20, Issue 6, 2015, Pages 615-616
|
|
Phase II trial of preoperative radiation with Concurrent Capecitabine, Oxaliplatin, and Bevacizumab followed by surgery and postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: 5-year clinical outcomes Ecog-Acrin cancer research group E3204
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CAPECITABINE;
FLUOROURACIL;
FOLINIC ACID;
OXALIPLATIN;
PLATINUM COMPLEX;
ACUTE TOXICITY;
ADJUVANT CHEMORADIOTHERAPY;
ARTICLE;
CANCER RECURRENCE;
FOLLOW UP;
HUMAN;
MAJOR CLINICAL STUDY;
MULTIPLE CYCLE TREATMENT;
OVERALL SURVIVAL;
PHASE 2 CLINICAL TRIAL;
POSTOPERATIVE COMPLICATION;
PREOPERATIVE RADIOTHERAPY;
PRIORITY JOURNAL;
RADIATION DOSE;
RECTUM CANCER;
RECURRENCE FREE SURVIVAL;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
ADULT;
AGED;
CANCER STAGING;
CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
FEMALE;
MALE;
MIDDLE AGED;
PATHOLOGY;
RECTAL NEOPLASMS;
TUMOR RECURRENCE;
VERY ELDERLY;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BEVACIZUMAB;
CAPECITABINE;
DISEASE-FREE SURVIVAL;
FEMALE;
FLUOROURACIL;
HUMANS;
LEUCOVORIN;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
ORGANOPLATINUM COMPOUNDS;
RECTAL NEOPLASMS;
|
|
EID: 84932624973
PISSN: 10837159
EISSN: 1549490X
Source Type: Journal
DOI: 10.1634/theoncologist.2015-0106 Document Type: Article |
|
Times cited : (45)
|
|
References (0)
|
